APTO - Aptose Biosciences Inc.
IEX Last Trade
0.2115
0.000 0.142%
Share volume: 695,807
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.21
-0.01
-0.04%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2023-08-10 | 2023-11-09 | 2024-11-09 | 2024-05-14 | 2024-08-08 | 2024-11-09 | |
| Assets | ||||||||
| Total Assets | 39.330 M | 26.575 M | 20.876 M | 12.989 M | 12.796 M | 10.949 M | 10.929 M | |
| Current Assets | 37.929 M | 25.259 M | 19.671 M | 11.894 M | 11.821 M | 10.159 M | 10.235 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 162.000 K | 217.000 K | 261.000 K | 600.000 K | 674.000 K | 593.000 K | 1.361 M | |
| Short Term Investments | 12.958 M | 14.906 M | 1.997 M | 0.000 | 1.982 M | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 22.762 M | 8.400 M | 15.720 M | 9.252 M | 7.346 M | 8.330 M | 7.962 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 183.000 K | 190.000 K | 170.000 K | 152.000 K | 125.000 K | 34.000 K | 30.000 K | |
| Other Assets | 1.218 M | 1.126 M | 1.035 M | 943.000 K | 850.000 K | 756.000 K | 664.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 39.330 M | 26.575 M | 20.876 M | 12.989 M | 12.796 M | 10.949 M | 10.929 M | |
| Total liabilities | 13.337 M | 12.789 M | 13.100 M | 15.890 M | 12.659 M | 13.125 M | 20.063 M | |
| Total current liabilities | 12.419 M | 11.972 M | 12.380 M | 15.269 M | 12.139 M | 12.711 M | 9.758 M | |
| Accounts Payable | 5.519 M | 3.501 M | 2.811 M | 6.046 M | 2.421 M | 7.111 M | 1.830 M | |
| Other liabilities | 918.000 K | 0.000 | 0.000 | 0.000 | 520.000 K | 414.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 10.000 M | |
| Other liabilities | 918.000 K | 0.000 | 0.000 | 0.000 | 520.000 K | 414.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 25.993 M | 13.786 M | 7.776 M | -2.901 M | 137.000 K | -2.176 M | -9.134 M | |
| Common stock | 508.313 M | 510.236 M | 515.673 M | 516.952 M | 529.631 M | 534.569 M | 534.564 M | |
| Retained earnings | -478.006 M | -492.135 M | -503.582 M | -515.537 M | -525.177 M | -532.429 M | -539.382 M |